Skip to main content

Treatment for late-stage prostate cancer patients: getting closer to a solution

22 Mar 16




Press and Communications Officer
Tel.+34 93 40 37255

The European Research Council (ERC) has devoted an ERC story to Xavier Salvatella, ICREA researcher and head of the Laboratory of Molecular Biophysics. Salvatella holds an ERC Consolidator Grant to study how the protein androgen receptor folds and how mutations in this protein are linked to drug resistance developed in late-stage prostate cancer patients. This research may open the door to new therapies.

The ERC piece includes the "Meet Our Scientists" video devoted to the researcher—the launch of which inspired this European organisation to write this article about him. The aim of the “Meet Our Scientists” series is to promote IRB Barcelona scientists, attract talent, and spread the word about the benefits of biomedical research.

About IRB Barcelona

Created in 2005 by the Generalitat de Catalunya (Government of Catalonia) and University of Barcelona, IRB Barcelona is a Severo Ochoa Centre of Excellence, a seal that was awarded in 2011. The institute is devoted to conducting research of excellence in biomedicine and to transferring results to clinical practice, thus improving people’s quality of life, while simultaneously promoting the training of outstanding researchers, technology transfer, and public communication of science. Its 27 laboratories and eight core facilities address basic questions in biology and are orientated to diseases such as cancer, metastasis, Alzheimer’s, diabetes, and rare conditions. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. It is located in the Barcelona Science Park. IRB Barcelona is a CERCA center, and a member of the Barcelona Institute of Science and Technology (BIST).